BSACI 2021 guideline for the management of egg allergy.

This guideline advises on the management of patients with egg allergy. Most commonly egg allergy presents in infancy, with a prevalence of approximately 2% in children and 0.1% in adults.

A meta-analysis of montelukast for recurrent wheeze in preschool children.

Unlabelled: There is conflicting evidence of the effectiveness of montelukast in preschool wheeze. A recent Cochrane review focused on its use in viral-induced wheeze; however, such subgroups are unlikely to exist in real life and change with time, recently highlighted in an international consensus report. We have therefore sought to investigate the effectiveness of montelukast in all children with preschool wheeze (viral-induced and multiple-trigger wheeze).

The RCPCH care pathway for children with venom allergies: an evidence and consensus based national approach.

Aims: The Royal College of Paediatrics and Child Health (RCPCH) Science & Research Department was commissioned by the Department of Health to develop national care pathways for children with allergies; the venom allergy pathway is the seventh pathway. The pathways focus on defining the competences to improve the equity of care received by children with allergic conditions.

Method: The RCPCH venom allergy pathway was developed by a multidisciplinary working group and was based on a comprehensive review of evidence.

The RCPCH care pathway for children with latex allergies: an evidence- and consensus-based national approach.

Aims: The Royal College of Paediatrics and Child Health (RCPCH) Science and Research Department was commissioned by the Department of Health to develop national care pathways for children with allergies; the latex allergy pathway is the seventh pathway. The pathways focus on defining the competences to improve the equity of care received by children with allergic conditions.

Method: The RCPCH latex allergy pathway was developed by a multidisciplinary working group and was based on a comprehensive review of evidence.

The RCPCH care pathway for children with drug allergies: an evidence and consensus based national approach.

Aims: The Royal College of Paediatrics and Child Health (RCPCH) was commissioned by the Department of Health to develop a drug allergy pathway. It focuses on defining the competences to improve the equity of care received by children.

Method: The drug pathway was developed by a multidisciplinary working group and was based on a comprehensive review of evidence.